Solid Biosciences (SLDB) Current Assets: 2017-2024
Historic Current Assets for Solid Biosciences (SLDB) over the last 7 years, with Sep 2024 value amounting to $179.5 million.
- Solid Biosciences' Current Assets rose 21.00% to $179.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $179.5 million, marking a year-over-year increase of 21.00%. This contributed to the annual value of $129.7 million for FY2023, which is 40.93% down from last year.
- According to the latest figures from Q3 2024, Solid Biosciences' Current Assets is $179.5 million, which was down 9.17% from $197.6 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Current Assets ranged from a high of $274.3 million in Q1 2021 and a low of $27.2 million during Q3 2020.
- Its 3-year average for Current Assets is $178.5 million, with a median of $179.5 million in 2024.
- As far as peak fluctuations go, Solid Biosciences' Current Assets crashed by 76.07% in 2020, and later skyrocketed by 779.21% in 2021.
- Over the past 5 years, Solid Biosciences' Current Assets (Quarterly) stood at $158.9 million in 2020, then skyrocketed by 40.09% to $222.6 million in 2021, then decreased by 1.34% to $219.6 million in 2022, then crashed by 40.93% to $129.7 million in 2023, then increased by 21.00% to $179.5 million in 2024.
- Its Current Assets was $179.5 million in Q3 2024, compared to $197.6 million in Q2 2024 and $214.2 million in Q1 2024.